Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT

被引：4
|
作者：
Cai, Jiayu [1 ,2 ]
Xu, Weizhi [1 ,2 ]
Meng, Tinghua [1 ,2 ]
Pang, YiZhen [1 ,2 ]
Chen, Haojun [1 ,2 ,3 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Nucl Med, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Minnan PET Ctr, Xiamen Canc Ctr,Sch Med, Xiamen, Peoples R China
[3] 55 Zhenhai Rd, Xiamen 361003, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 08期
基金：
中国国家自然科学基金;
关键词：
F-18-FDG; Ga-68-FAPI; Ga-68-PSMA; neuroendocrine adenocarcinoma; neuroendocrine prostate cancer; PET/CT;
D O I：
10.1097/RLU.0000000000004719
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present Ga-68-PSMA (prostate-specific membrane antigen), Ga-68-FAPI, and F-18-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.
引用
收藏
页码：743 / 745
页数：3
相关论文
共 50 条
  • [21] 18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule
    Chen, Haojun
    Pang, Yizhen
    Meng, Tinghua
    Yu, Xiuyi
    Sun, Long
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : 424 - 426
  • [22] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases
    Deng, Maoxue
    Chen, Yue
    Cai, Liang
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : 589 - 591
  • [23] 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis
    Wu, Simin
    Pang, Yizhen
    Zhao, Liang
    Zhao, Long
    Chen, Haojun
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (10) : 847 - 849
  • [24] Primary Adenosquamous Carcinoma of the Prostate With Multiple Heterogenic Metastases Demonstrated on 68Ga-PSMA and 18F-FDG PET/CT Imaging
    Yang, Jinhui
    Xiao, Ling
    Gao, Xiaomei
    Tang, Yongxiang
    Hu, Shuo
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 180 - 181
  • [25] Mesenteric Mesonephric Adenocarcinoma on 68Ga-FAPI PET/CT
    Liu, Huipan
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) : 197 - 198
  • [26] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [27] 68Ga-FAPI Versus 18F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery
    Zhang, Linqi
    Liu, Zhidong
    Jiang, Shuqin
    He, Qiao
    Zhang, Rusen
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : E651 - E653
  • [28] Significantly Higher 68Ga-FAPI Than 18F-FDG Uptake by Hidradenocarcinoma of Head and Neck on PET/CT
    Ding, Haoyuan
    Wang, Yudi
    Liang, Juan
    Liu, Ya
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 466 - 467
  • [29] Rectal Carcinoma on 68Ga-PSMA PET/CT
    Huang, Yi-Tung Tom
    Fong, William
    Thomas, Paul
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) : E167 - E168
  • [30] Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET/CT in common gynecological malignancies
    Li, Tengfei
    Zhang, Jintao
    Yan, Yuanzhuo
    Zhang, Yue
    Pei, Wenjie
    Hua, Qingchu
    Chen, Yue
    CANCER IMAGING, 2025, 25 (01)
12345